Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors
- Le Gouill, S.
- Długosz-Danecka, M.
- Rule, S.
- Zinzani, P.L.
- Goy, A.
- Smith, S.D.
- Doorduijn, J.K.
- Panizo, C.
- Shah, B.D.
- Davies, A.J.
- Eek, R.
- Jacobsen, E.
- Kater, A.P.
- Robak, T.
- Jain, P.
- Calvo, R.
- Tao, L.
- Wang, M.
ISSN: 1592-8721, 0390-6078
Datum der Publikation: 2024
Ausgabe: 109
Nummer: 1
Seiten: 343-350
Art: Brief